Source: By Zachary Stieber
Merck is set to get $712 per treatment course for its COVID-19 pill from the U.S. government—even as it costs a fraction of that to produce, and is reportedly on track for a price of $12 in India.
Big Pharma, Enemy of the People!’, Merck
